http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2625028-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a6d063d2c08b0a5fde8f94179e0678b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83a459ba3f0fcfe997d77c889c49ac82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76ee6f2f32126c3f3e06cbe9461c0d6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d52c0f6d5cbdffa5b39122b7c7f205fc |
| publicationDate | 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2625028-C1 |
| titleOfInvention | Method for forecasting the duration of ischemia of myocardium in patients with copd with copd and related chd |
| abstract | FIELD: medicine. n SUBSTANCE: assessing the acute period when entering the clinic level of markers of inflammation in the blood, IL-6, CRP, TNF-α and instrumental studies of spirography, Holter monitoring of ECG. Then calculating the forecasting coefficient by the formula: Kprogn Dlit=1.19532-0.171896*lechen-0,00392163*CRB+0.000232908*IL_6-0.00328536*FNO-0.00626344*OFB_1+0.00898338*prist_1+0.00282975*dlit_1-0.00522293*kachel+0.000463957*mokrota, where lechen is the type of treatment (1 - standard therapy, 2 - therapy with roflumilast supplementation), CRB - C-reactive protein, measured in venous blood, mg/L, IL_6 - interleukin-6, measured in venous blood, pg/ml, FNO - tumour necrosis factorα, Measured in venous blood, pg/ml, OFB_1 - FEV-1 by spirography, %, prist_1 - the number of attacks of angina pectoris per week on the diary of self-control, dlit_1 - duration of myocardial ischemia per day according to Holter ECG monitoring, kachel - the number of cough pushes per day on the self-monitoring diary; Mokrota - the amount of sputum produced per day by self-monitoring diary, ml, and at KprognDlit 0.63 or more the effectiveness of standard therapy including berodual, dexamethasone, ceftriaxone, euphyllin, high and additional prescription of medications is not required; When detecting KProGnDlit less than when KprognDlit is detected, less than 0.63 standard therapy will not give the proper effect and it will be necessary to add roflumilast. n EFFECT: use of the method makes it possible to predict the effectiveness of the anti-inflammatory therapy scheme with high accuracy even before its practical application in patients with COPD in combination with IHD. n 2 tbl |
| priorityDate | 2016-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.